131 related articles for article (PubMed ID: 7408140)
1. Persantine-aspirin reinfarction study. Design, methods and baseline results. By the persantine-aspirin reinfarction study research group.
Circulation; 1980 Sep; 62(3 Pt 2):II1-42. PubMed ID: 7408140
[TBL] [Abstract][Full Text] [Related]
2. The Persantine-aspirin reinfarction study. The Persantine-aspirin Reinfarction Study (PARIS) research group.
Circulation; 1980 Dec; 62(6 Pt 2):V85-8. PubMed ID: 7002354
[TBL] [Abstract][Full Text] [Related]
3. [Persantin and aspirin in coronary heart disease. The persantin-aspirin reinfarction study group (PARIS)].
MMW Munch Med Wochenschr; 1980 Dec; 122(49):1761-71. PubMed ID: 6779148
[TBL] [Abstract][Full Text] [Related]
4. Secondary prevention of myocardial infarction.
Davies JA
Int J Clin Pharmacol Res; 1985; 5(5):303-7. PubMed ID: 3905632
[TBL] [Abstract][Full Text] [Related]
5. Persantine-Aspirin Reinfarction Study. Part II. Secondary coronary prevention with persantine and aspirin.
Klimt CR; Knatterud GL; Stamler J; Meier P
J Am Coll Cardiol; 1986 Feb; 7(2):251-69. PubMed ID: 2868029
[TBL] [Abstract][Full Text] [Related]
6. [Various observations on the results of the "Aspirin myocardial infarction study" and the "Persantine-aspirin reinfarction study" in the United States].
Lubsen J
Ned Tijdschr Geneeskd; 1981 Oct; 125(40):1606-9. PubMed ID: 7029311
[No Abstract] [Full Text] [Related]
7. Antiplatelet therapy and progression of coronary artery disease: a placebo-controlled trial with angiographic and clinical follow-up after myocardial infarction.
Dieker HJ; French JK; Joziasse IC; Brouwer MA; Elliott J; West TM; Webber BJ; Verheugt FW; White HD
Am Heart J; 2007 Jan; 153(1):66.e1-8. PubMed ID: 17174639
[TBL] [Abstract][Full Text] [Related]
8. Persantine and aspirin in coronary heart disease. The Persantine-Aspirin Reinfarction Study Research Group.
Circulation; 1980 Sep; 62(3):449-61. PubMed ID: 7398002
[TBL] [Abstract][Full Text] [Related]
9. Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-blind, 30-day trial.
Serebruany VL; Malinin AI; Pokov AN; Hanley DF
Clin Ther; 2008 Feb; 30(2):249-59. PubMed ID: 18343263
[TBL] [Abstract][Full Text] [Related]
10. Rationale, design and organization of the Second Chinese Cardiac Study (CCS-2): a randomized trial of clopidogrel plus aspirin, and of metoprolol, among patients with suspected acute myocardial infarction. Second Chinese Cardiac Study (CCS-2) Collaborative Group.
Second Chinese Cardiac Study (CCS-2) Collaborative Group
J Cardiovasc Risk; 2000 Dec; 7(6):435-41. PubMed ID: 11189013
[TBL] [Abstract][Full Text] [Related]
11. Summary of ongoing clinical trials of platelet-active drugs in cardiovascular disease.
Passamani ER
Circulation; 1980 Dec; 62(6 Pt 2):V106-10. PubMed ID: 7002348
[TBL] [Abstract][Full Text] [Related]
12. [Results of ambulatory follow-up of patients after myocardial infarction treated with platelet aggregation inhibitors and antithrombotic drugs].
Markiewicz M; Rymar B; Florkiewicz H; Wysokiński A
Pol Tyg Lek; 1983 Nov; 38(48):1501-3. PubMed ID: 6382203
[No Abstract] [Full Text] [Related]
13. An update on aspirin in the primary prevention of cardiovascular disease.
Eidelman RS; Hebert PR; Weisman SM; Hennekens CH
Arch Intern Med; 2003 Sep; 163(17):2006-10. PubMed ID: 14504112
[TBL] [Abstract][Full Text] [Related]
14. Role of platelet-active drugs in coronary artery disease.
Sherry S
Cardiovasc Clin; 1983; 14(1):173-89. PubMed ID: 6352025
[No Abstract] [Full Text] [Related]
15. Higher rates of coronary angiography and revascularization following myocardial infarction may be associated with greater survival in the United States than in Canada. The CARS Investigators (Coumadin/Aspirin Reinfarction Study).
Langer A; Fisher M; Califf RM; Goodman S; O'Connor CM; Harrington RA; Fuster V
Can J Cardiol; 1999 Oct; 15(10):1095-102. PubMed ID: 10523476
[TBL] [Abstract][Full Text] [Related]
16. Failure of aspirin to prevent myocardial infarction and adverse outcome during follow-up - a large series of all-comers.
Mikkelsson J; Eskola M; Nikus K; Karhunen PJ; Niemela K
Ann Med; 2008; 40(4):296-302. PubMed ID: 18428022
[TBL] [Abstract][Full Text] [Related]
17. The aspirin myocardial infarction study: final results. The Aspirin Myocardial Infarction Study research group.
Circulation; 1980 Dec; 62(6 Pt 2):V79-84. PubMed ID: 7438383
[TBL] [Abstract][Full Text] [Related]
18. Update on aspirin in the treatment and prevention of cardiovascular disease.
Hennekens CH
Am J Manag Care; 2002 Dec; 8(22 Suppl):S691-700. PubMed ID: 12512736
[TBL] [Abstract][Full Text] [Related]
19. [Prognostic value of dipyridamole echocardiography in 1st acute uncomplicated myocardial infarction].
Sánchez P; Paré JC; Azqueta M; Sanz GA
Med Clin (Barc); 1998 Feb; 110(7):241-6. PubMed ID: 9562947
[TBL] [Abstract][Full Text] [Related]
20. [Secondary prevention after acute myocardial infarction: aspirin, warfarin or both?].
Reikvam A; Madsen S; Landmark K
Tidsskr Nor Laegeforen; 2003 Jun; 123(13-14):1838-40. PubMed ID: 12830258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
